Physician profile
Viet Tran
NPI 1235465311
$46,987.12
in general payments reported to CMS, 2019-2025
32 companies · $3,034 in 2025
The $3,034 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,289 · 2021: $2,223 · 2022: $5,710 · 2023: $16K · 2024: $3,306 · 2025: $3,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $6,666 · Travel and Lodging: $4,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,437.50 |
| Food and Beverage | $6,666.40 |
| Travel and Lodging | $4,346.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,457.34 | 2019-2025 | Watchman Access System, Watchman Flx, General - Brady |
| Medical Device Business Services, INC. | $14,247.10 | 2023-2024 | Carto 3 |
| Abbott Laboratories | $10,023.07 | 2019-2025 | Aveir, Gallant, Ensite |
| Biosense Webster, INC. | $1,881.59 | 2019-2025 | Carto 3, Qdot Micro, Nuvision Ice Catheter |
| Biotronik INC. | $1,365.93 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Medtronic, INC. | $629.22 | 2022-2024 | Resolute Onyx |
| Impulse Dynamics (USA) INC. | $533.24 | 2022-2023 | Optimizer |
| Philips North America LLC | $405.81 | 2022-2024 | (5044) Mcot |
| Acutus Medical, INC. | $392.98 | 2022-2023 | |
| Medtronic Vascular, INC. | $339.80 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.99 | 2019-2021 | |
| Atricure, INC. | $238.76 | 2023 | |
| Cardiva Medical, INC. | $205.96 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novartis Pharmaceuticals Corporation | $167.75 | 2020-2022 | |
| Amgen INC. | $155.70 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $92.01 | 2021-2022 | |
| Ebr Systems, INC. | $74.10 | 2025 | |
| Sanofi-Aventis U.S. LLC | $68.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.00 | 2019-2022 | |
| Elutia, INC. | $40.64 | 2021-2024 | Ecm Patch,Pouch |
| Janssen Pharmaceuticals, INC | $40.11 | 2020-2022 | |
| Irhythm Technologies, INC. | $37.11 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $33.62 | 2021-2022 | |
| Bardy Diagnostics, INC. | $30.00 | 2021 | |
| Terumo Medical Corporation | $29.63 | 2022 | |
| Pfizer INC. | $25.01 | 2022 | |
| Nestle Healthcare Nutrition INC. | $22.81 | 2023 | |
| Akcea Therapeutics, INC. | $22.00 | 2020 | |
| Novo Nordisk INC | $21.40 | 2023 | Ozempic |
| Abiomed | $20.98 | 2020 | |
| Medtronic USA, INC. | $16.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viet Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.